New Drug ApprovalInnovative Brekiya® DHE Autoinjector Launched by Amneal for Rapid Relief o... Innovative Brekiya® DHE Autoinjector Launched by Amneal for Rapid Relief o... Read Post »
New Drug ApprovalKygevvi Brings Hope for Patients With Rare Mitochondrial Disorder Kygevvi Brings Hope for Patients With Rare Mitochondrial Disorder Read Post »
Clinical TrailsFDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in... FDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in... Read Post »
Lifestyle WellnessChamomile Extract for Better Sleep and Anxiety Reduction: What Research Sho... Chamomile Extract for Better Sleep and Anxiety Reduction: What Research Sho... Read Post »
Health TidingsDupixent® (Dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechno... Dupixent® (Dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechno... Read Post »
ResearchSemaglutide Users Report Major Reduction in “Food Noise” and Better Men... Semaglutide Users Report Major Reduction in “Food Noise” and Better Men... Read Post »
Clinical TrailsGefurulimab Symptom Relief in Myasthenia Gravis: PREVAIL Phase 3 Gefurulimab Symptom Relief in Myasthenia Gravis: PREVAIL Phase 3 Read Post »
Drugs Safety Alert ResearchFDA’s New Move to Protect Children from Unapproved Fluoride Drug Prod... FDA’s New Move to Protect Children from Unapproved Fluoride Drug Prod... Read Post »
Health TidingsYeztugo Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical... Yeztugo Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical... Read Post »
Policy & AcquisitionsPfizer vs. Novo Nordisk: The High-Stakes Battle for Metsera Pfizer vs. Novo Nordisk: The High-Stakes Battle for Metsera Read Post »
Drugs Safety Alert ResearchTeva Pharmaceuticals Issues Voluntary Recall of Prazosin Hydrochloride Caps... Teva Pharmaceuticals Issues Voluntary Recall of Prazosin Hydrochloride Caps... Read Post »
Clinical TrailsNovartis Presents Positive Phase III NEPTUNUS-1 and NEPTUNUS-2 Trial Result... Novartis Presents Positive Phase III NEPTUNUS-1 and NEPTUNUS-2 Trial Result... Read Post »
Clinical TrailsBridgeBio Announces Positive Phase 3 CALIBRATE Trial Results for Encaleret ... BridgeBio Announces Positive Phase 3 CALIBRATE Trial Results for Encaleret ... Read Post »
Drugs Safety Alert ResearchFDA Safety Alert: Increased Reports of Severe Allergic Reactions to Specifi... FDA Safety Alert: Increased Reports of Severe Allergic Reactions to Specifi... Read Post »
Disease & Drugs New Drug ApprovalNew FDA Indication for WINREVAIR: Reducing Hospitalizations and Mortality i... New FDA Indication for WINREVAIR: Reducing Hospitalizations and Mortality i... Read Post »
Health TidingsFDA Issues Complete Response Letter to Regeneron for Eylea HD Prefilled-Syr... FDA Issues Complete Response Letter to Regeneron for Eylea HD Prefilled-Syr... Read Post »
Health TidingsFDA Issues Complete Response Letter to Sydnexis for SYD-101 Pediatric Myopi... FDA Issues Complete Response Letter to Sydnexis for SYD-101 Pediatric Myopi... Read Post »
Health TidingsNeutrogena Makeup Remover Towelettes Recall 2025: What You Need to Know Abo... Neutrogena Makeup Remover Towelettes Recall 2025: What You Need to Know Abo... Read Post »
Clinical TrailsIntellia Pauses Phase 3 CRISPR Trials after Life-Threatening Liver Injury i... Intellia Pauses Phase 3 CRISPR Trials after Life-Threatening Liver Injury i... Read Post »
Drugs Safety Alert ResearchFDA Tightens Warnings on Tranexamic Acid Amid Deadly Mix-Ups with Spinal An... FDA Tightens Warnings on Tranexamic Acid Amid Deadly Mix-Ups with Spinal An... Read Post »
Clinical TrailsSanofi’s Efdoralprin Alfa Achieves All Primary Endpoints in Phase 2 ElevA... Sanofi’s Efdoralprin Alfa Achieves All Primary Endpoints in Phase 2 ElevA... Read Post »
Clinical TrailsInnovent and Lilly’s Mazdutide Outperforms Semaglutide in Phase 3 DREAMS-... Innovent and Lilly’s Mazdutide Outperforms Semaglutide in Phase 3 DREAMS-... Read Post »
New Drug ApprovalBayer’s Lynkuet: FDA Approves Non-Hormonal Pill for Hot Flashes in Menopa... Bayer’s Lynkuet: FDA Approves Non-Hormonal Pill for Hot Flashes in Menopa... Read Post »
New Drug ApprovalLupin Launches Authorized Generic and Endo Launches First Generic Versions ... Lupin Launches Authorized Generic and Endo Launches First Generic Versions ... Read Post »
New Drug ApprovalFDA Re-approves GSK’s Blenrep (Belantamab Mafodotin-blmf) Combo for Relap... FDA Re-approves GSK’s Blenrep (Belantamab Mafodotin-blmf) Combo for Relap... Read Post »
Clinical TrailsLong-Term SELECT Trial: Semaglutide Cuts Cardiovascular Events by 20% beyon... Long-Term SELECT Trial: Semaglutide Cuts Cardiovascular Events by 20% beyon... Read Post »
Clinical TrailsNipocalimab Delivers Breakthrough Efficacy and Safety in Sjögren’s Disea... Nipocalimab Delivers Breakthrough Efficacy and Safety in Sjögren’s Disea... Read Post »
New Drug ApprovalFDA Expands Approval of Revumenib for NPM1-Mutated Relapsed or Refractory A... FDA Expands Approval of Revumenib for NPM1-Mutated Relapsed or Refractory A... Read Post »
Clinical TrailsAlector Faces Major Setback as Latozinemab Fails Phase 3 Trial, Cuts 50% St... Alector Faces Major Setback as Latozinemab Fails Phase 3 Trial, Cuts 50% St... Read Post »
Health TidingsFDA Issues Complete Response Letter to Xbrane Biopharma for Ranibizumab Bio... FDA Issues Complete Response Letter to Xbrane Biopharma for Ranibizumab Bio... Read Post »
Clinical TrailsModerna’s mRNA‑1647 CMV Vaccine Fails in Late‑Stage Trial, Showing On... Moderna’s mRNA‑1647 CMV Vaccine Fails in Late‑Stage Trial, Showing On... Read Post »
Health Tidings New Drug ApprovalMounjaro Now Cipla’s Yurpeak: A New Chapter for Tirzepatide in India Mounjaro Now Cipla’s Yurpeak: A New Chapter for Tirzepatide in India Read Post »
Clinical Trails ResearchFirst Successful Restoration of Central Vision in Dry AMD Using Subretinal ... First Successful Restoration of Central Vision in Dry AMD Using Subretinal ... Read Post »
New Drug ApprovalGlaukos’ Epioxa™ Wins FDA Nod: A Game-Changer for Keratoconus Patients Glaukos’ Epioxa™ Wins FDA Nod: A Game-Changer for Keratoconus Patients Read Post »
New Drug ApprovalFDA Approves Gazyva for Lupus Nephritis, Extending Roche and Biogen’s CD2... FDA Approves Gazyva for Lupus Nephritis, Extending Roche and Biogen’s CD2... Read Post »
ResearchWhat the WHO 2025 Antibiotic Resistance Report Warns: The World’s Fight a... What the WHO 2025 Antibiotic Resistance Report Warns: The World’s Fight a... Read Post »
ResearchFSSAI Bans Misleading Use of ORS Label on Fruit Juices: Dr. Sivaranjani San... FSSAI Bans Misleading Use of ORS Label on Fruit Juices: Dr. Sivaranjani San... Read Post »
Health TidingsFDA Expands Recall of Cinnamon over Dangerous Lead Levels FDA Expands Recall of Cinnamon over Dangerous Lead Levels Read Post »
Clinical TrailsNovo Nordisk’s Monlunabant Shows Promising Weight Loss and Metabolic Bene... Novo Nordisk’s Monlunabant Shows Promising Weight Loss and Metabolic Bene... Read Post »
Health TidingsFDA Issues Complete Response Letter to Xspray Pharma’s Dasynoc Due to GMP... FDA Issues Complete Response Letter to Xspray Pharma’s Dasynoc Due to GMP... Read Post »
Clinical TrailsHigher-Dose Semaglutide Achieves Historic 21% Weight Loss in Landmark STEP ... Higher-Dose Semaglutide Achieves Historic 21% Weight Loss in Landmark STEP ... Read Post »
Clinical TrailsFDA Approves Early Use of RINVOQ before TNF Blockers for Select IBD Patient... FDA Approves Early Use of RINVOQ before TNF Blockers for Select IBD Patient... Read Post »
Clinical Trails Drugs Safety AlertFDA Flags New Safety Risk for Carvykti: Immune Effector Cell Associated Ent... FDA Flags New Safety Risk for Carvykti: Immune Effector Cell Associated Ent... Read Post »
Clinical TrailsRegeneron’s DB-OTO Gene Therapy Shows Breakthrough Hearing Restoration in... Regeneron’s DB-OTO Gene Therapy Shows Breakthrough Hearing Restoration in... Read Post »
New Drug ApprovalFDA Approves Lasix ONYU: At-Home Drug-Device Combination for Subcutaneous F... FDA Approves Lasix ONYU: At-Home Drug-Device Combination for Subcutaneous F... Read Post »
New Drug ApprovalFDA Approves Libtayo® (cemiplimab-rwlc) for Adjuvant Treatment of High-Ris... FDA Approves Libtayo® (cemiplimab-rwlc) for Adjuvant Treatment of High-Ris... Read Post »
ResearchVertex’s Journavx, Eisai Biogen’s Leqembi Iqlik, and Gilead’s Yeztugo... Vertex’s Journavx, Eisai Biogen’s Leqembi Iqlik, and Gilead’s Yeztugo... Read Post »
Clinical Trails36-Month Phase I Results Highlight Bemdaneprocel Stem Cell Therapy Promise ... 36-Month Phase I Results Highlight Bemdaneprocel Stem Cell Therapy Promise ... Read Post »
Clinical TrailsNeflamapimod Delivers Clinical and Biomarker Benefits in Dementia with Lewy... Neflamapimod Delivers Clinical and Biomarker Benefits in Dementia with Lewy... Read Post »
Clinical TrailsValbenazine from KINECT-PRO Study Delivers Superior Well-Being Results for ... Valbenazine from KINECT-PRO Study Delivers Superior Well-Being Results for ... Read Post »
